The European Commission is preparing to amend the Authorisation List (Annex XIV to REACH) entries owing to the additional identification of the four phthalates as substances of very high concern (SVHCs) with endocrine disrupting effects on human health or the environment. Consequently, some uses previously exempted may require authorisation.
In 2014 and 2017 the four phthalates DEHP, DBP, BBP, DIBP were identified as substances of very high concern (SVHCs) for authorisation due to endocrine disrupting properties with effects on human health and, in the case of DEHP, also on the environment. The Candidate List entries for these substances were updated accordingly.
The four phthalates had earlier been identified as SVHCs and subsequently added to the Authorisation List in 2011 and 2012 due to their classification as toxic for reproduction.
Later this year, the European Commission intends to amend the current entries of these substances in the Authorisation List to also include the endocrine disrupting properties as intrinsic properties referred to in Article 57.
ECHA, on behalf of the Commission, is now launching a public consultation targeted at the sectors affected by such amendment of the Authorisation List. In particular, information is sought about the uses that might no longer be covered by generic exemptions from the authorisation requirement, such as uses in food contact materials and in medical devices, as well as transitional arrangements, exemptions and review periods.
CONTINUE READING ON echa.europa.eu